Could new imaging probes spot breast cancer more accurately?
NCT ID NCT06715826
First seen Feb 01, 2026 · Last updated Jun 22, 2026 · Updated 23 times
Summary
This study tests two new radioactive imaging probes that target specific markers on breast cancer cells. Researchers will use PET/CT scans to see how well these probes find tumors and their spread in 200 women with breast cancer. The goal is to improve diagnosis and help guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
RECRUITINGShanghai, Shanghai Municipality, 200127, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[18F]F-RESCA-RT4 and [18F]F-RESCA-RB14 (radioactive imaging probes)
What this could lead to
If successful, these probes could provide a more accurate way to detect breast cancer and its spread, helping doctors choose the right treatments.
What could go wrong
This is an early-phase study with only 200 participants, so results may not apply to all patients. The probes are experimental and may not prove better than current imaging methods.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.